C.M. Bidwell & Associates’s Globus Medical GMED Stock Holding History

C.M. Bidwell & Associates’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,095	Closed	-$91K	–	425
2018 Q4	$91K	Sell	2,095 -165	-7%	-$8.23K	0.1%	186
2018 Q3	$128K	Sell	2,260 -235	-9%	-$12.4K	0.12%	163
2018 Q2	$126K	Sell	2,495 -25	-1%	-$1.3K	0.12%	165
2018 Q1	$126K	Buy	+2,520	New	+$118K	0.12%	173
2017 Q3	–	Sell	-650	Closed	-$22K	–	332
2017 Q2	$22K	Sell	650 -3,345	-84%	-$105K	﹤0.01%	220
2017 Q1	$118K	Buy	+3,995	New	+$109K	0.03%	183
2016 Q2	–	Sell	-6,385	Closed	-$152K	–	274
2016 Q1	$152K	Buy	+6,385	New	+$156K	0.04%	202
2015 Q1	–	Sell	-8,045	Closed	-$191K	–	237
2014 Q4	$191K	Buy	+8,045	New	+$178K	0.04%	153

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

C.M. Bidwell & Associates's GMED Position: Q1 2019 in Review

C.M. Bidwell & Associates sold out of Globus Medical (GMED) in Q1 2019, closing a stake of 2,095 shares — an estimated $91K sold.

C.M. Bidwell & Associates first reported a position in GMED in Q4 2014 and held it in 8 quarters. The position peaked at $191K in Q4 2014. 269 funds tracked by Wall St. Rank hold GMED as of Q1 2019.

C.M. Bidwell & Associates reported no remaining Globus Medical position as of Q1 2019 after selling out during the quarter.
C.M. Bidwell & Associates sold 2,095 Globus Medical shares in Q1 2019, an estimated $91K.
C.M. Bidwell & Associates first reported a position in Globus Medical in Q4 2014 and held it in 8 quarters.
C.M. Bidwell & Associates's Globus Medical position peaked at $191K in Q4 2014.
269 funds tracked by Wall St. Rank held Globus Medical as of Q1 2019.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2019, filed 15 May 2019.